why choose us

First received: September 03, 2024

Clinical Trial: Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: A Phase 2a Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of ATI-2138 Administered Over 12 Weeks in Participants With Moderate to Severe Ato

Brief Summary: This is a Phase 2 open label study of ATI-2138 in participants with moderate to severe atopic dermatitis.

Read more